Gilead Sciences Inc.'s Upcoming Catalyst(s)

Fool.com Headlines http://ift.tt/1r9yJKA Gilead's Sciences' idelalisib will be used in combination with Roche and Biogen Idec's Rituxan. An FDA approval is key, with Infinity Pharmaceuticals hot on its heels.